Section Arrow
Quote
ARWR.NASDAQ
- Arrowhead Pharmaceuticals
Quotes are at least 15-min delayed:2025/12/31 13:48 EST
Regular Hours
Last
 66.27
-0.98 (-1.46%)
Day High 
67.255 
Prev. Close
67.25 
1-M High
72.36 
Volume 
402.78K 
Bid
66.27
Ask
66.37
Day Low
66 
Open
66.505 
1-M Low
52.23 
Market Cap 
9.13B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 68.01 
20-SMA 67.24 
50-SMA 51.92 
52-W High 72.36 
52-W Low 9.57 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.01/-4.34
Enterprise Value
9.45B
Balance Sheet
Book Value Per Share
3.43
Cash Flow
Cash Flow Yield
0.02
Income Statement
Total Revenue
829.45M
Operating Revenue Per Share
1.89
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
MREOMereo BioPharma Group plc0.35045-0.02005-5.41%-- 
VNDAVanda Pharmaceuticals9.005+1.975+28.09%126.25PE
SLSSELLAS Life Sciences Group3.675+0.365+11.03%-- 
CORTCorcept Therapeutics35.3025-34.8925-49.71%81.32PE
RXRXRecursion Pharmaceuticals4.105-0.005-0.12%-- 
Industry overview quotes are at least 15 minutes delayed
Business Description
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.